Fauci warns about hydroxychloroquine

27 May 2020 - Top administration expert airs differences with Trump on pandemic response. ...

Read more →

‘Vaccine nationalism’: a new dynamic in the race to quash coronavirus

27 May 2020 - International pursuit for a shot is shifting into a contest of which world power can immunise its ...

Read more →

COVID-19: researchers halt patient recruitment for hydroxychloroquine trial

28 May 2020 - Australian researchers have suspended patient recruitment in a major clinical trial of the controversial anti-malaria drug ...

Read more →

European medicines regulatory network fully mobilised in fight against COVID-19

28 May 2020 - The development and availability of medicines and vaccines for all patients in the European Union, including those ...

Read more →

Tax payers paid to develop remdesivir but will have no say when Gilead sets the price

27 May 2020 - Critics say government deserves more credit for tens of millions in public money spent to develop coronavirus ...

Read more →

Australia avoids 'risky business' of coronavirus vaccine sweepstakes

27 May 2020 - Australia is avoiding huge financial risks by staying out of the global sweepstakes on coronavirus vaccines. ...

Read more →

COVID-19: UK authorises anti-viral drug remdesivir

26 May 2020 - A drug treatment called remdesivir that appears to shorten recovery time for people with coronavirus is ...

Read more →

EMA commissions independent research to prepare for real world monitoring of COVID-19 vaccines

27 May 2020 - EMA is engaging early with researchers to ensure that a European infrastructure will be in place to ...

Read more →

WHO pauses hydroxycholoroquine arm in COVID-19 trial

26 May 2020 - The World Health Organisation has announced a temporary pause on a clinical trial arm testing hydroxycholoroquine ...

Read more →

EMA calls for high-quality observational research in context of COVID-19

26 May 2020 - For observational studies of real world data in COVID-19, EMA calls for transparency for protocols and results, ...

Read more →

Australians stick with malaria drug hydroxychoroquine trial

26 May 2020 - Australian researchers are pressing ahead with administering the controversial antimalarial drug hydroxychloroquine in at least one ...

Read more →

SMC response to COVID-19

22 May 2020 - To prioritise and support the capacity of health and social care services, Healthcare Improvement Scotland and the ...

Read more →

First generic version of Gilead’s remdesivir will be sold by a Bangladesh drug maker

22 May 2020 - A drug maker in Bangladesh has become the first company to sell a generic version of ...

Read more →

Inside the science: companies racing to develop a COVID-19 vaccine

25 May 2020 - Even as some states move to ease the lockdowns that have cost tens of millions of ...

Read more →

WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

26 May 2020 - The World Health Organisation has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to ...

Read more →